Visitors must enter the building through the front lobby entrance on Fishers Lane after 7:00 a.m. A valid, government-issued photo ID (if you are an international visitor, your passport) must be presented to the security guards. Security screenings are required for anyone not in possession of a valid HHS badge.
NIAID is convening a scientific agenda-setting meeting to reshape our approach to universal influenza vaccine development. Specifically, NIAID seeks to identify gaps in knowledge critical to the development of universal influenza vaccines and propose research strategies to address these gaps. Ultimately, this will lead to a new strategic plan for NIAID universal influenza vaccine research that will guide future directions for the portfolio. The need for an improved approach to influenza immunization is clear: Seasonal influenza causes significant morbidity and mortality each year and the current seasonal influenza vaccines provide, at most, 60% protection against circulating viruses. Novel influenza viruses regularly emerge and can cause pandemics associated with even higher morbidity and mortality. Thus, development of a universal influenza vaccine which is broadly protective and can be given less frequently than the current seasonal vaccine is a high priority for NIAID.
Wednesday, June 28, 2017 - Thursday, June 29, 2017 8:00 AM - 12:00 PMEastern Time
5601 Fishers Lane Conference Ctr, Grand Hall 1D135601 Fishers LaneRockville, Maryland 20852USA
Cvent Online Event Registration Software | Copyright © 2000-2017 Cvent, Inc. All rights reserved.